Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment
Sponsored by Karolinska Institutet
About this trial
Last updated 2 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 5 months ago
What is this trial about?
What are the Participation Requirements?
Validation cohort:
Inclusion Criteria:
- Patients undergoing direct current cardioversion successfully for treatment of atrial
fibrillation or atrial flutter and have a normal heart rhythm after the treatment.
Exclusion Criteria:
- Patients with implantable cardiac devices.
Clinical implementation cohort:
Inclusion Criteria:
- Patients planned for direct current cardioversion for treatment of atrial fibrillation
or atrial flutter.
Exclusion Criteria:
- Patients with implantable cardiac devices.
- Patients with a spontaneous return to sinus rhythm diagnosed at a screening visit 2 to
4 weeks prior to the scheduled treatment with direct current cardioversion.